JPMorgan Asset Arm Fronts Fees in Mass Tort Firm Investments

JPMorgan Asset Management is entering the litigation finance space by advancing capital to mass tort law firms against future fee recoveries, signaling growing institutional appetite for lower-risk, post-settlement legal assets that offer predictable, market-uncorrelated returns, Emily Siegel reports. Seeger Weiss and Simmons Hanly Conroy, the firms transacting with JP Morgan Asset Management, have been involved in suits over the opioid crisis and cases against Ozempic manufacturer NovoNordisk and Norfolk Southern, among others.